US Stock MarketDetailed Quotes

APRE Aprea Therapeutics

Watchlist
  • 3.250
  • -0.100-2.99%
Close Nov 15 16:00 ET
  • 3.250
  • 0.0000.00%
Post 20:01 ET
17.66MMarket Cap-1160P/E (TTM)

About Aprea Therapeutics Company

Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wen Jie Bao in 2002 and is headquartered in Doylestown, PA.

Company Profile

SymbolAPRE
Company NameAprea Therapeutics
Listing DateOct 3, 2019
Issue Price15.00
Founded2002
CEODr. Oren Gilad, PhD
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address3805 Old Easton Road
CityDoylestown
ProvincePennsylvania
CountryUnited States of America
Zip Code18902
Phone1-617-463-9385
Websitehttp://www.aprea.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Oren Gilad, PhD
  • Director, President and Chief Executive Officer
  • 877.43K
  • John P. Hamill
  • Senior Vice President, Chief Financial Officer, Secretary and Principal Accounting Officer
  • 908.38K
  • Dr. Richard Peters, M.D.,PhD
  • Chairman of the Board
  • 61.16K
  • Dr. Rifat Pamukcu, M.D.
  • Director
  • --
  • Dr. Bernd R. Seizinger, M.D.,PhD
  • Independent Director
  • 58.73K
  • John B. Henneman, III
  • Lead Independent Director
  • 86.23K
  • Dr. Rifat Pamukcu, M.D.
  • Independent Director
  • 57.23K
  • Dr. Jean-Pierre Bizzari, M.D.
  • Independent Director
  • 38.44K
  • Dr. Gabriela Gruia, M.D.
  • Independent Director
  • 52.38K
  • Michael Grissinger
  • Independent Director
  • 62.73K
  • Marc Duey
  • Independent Director
  • 53.23K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data